Éditeur(s) : HAL CCSD Elsevier Masson
Résumé : International audience
Objectifs. - Évaluer les effets du triathlon classique (1,5 km natation, 40 km cyclisme, 10 km course à pied) sur la capacité de diffusion pulmonaire (DLCO) 24 heures après la compétition. Méthodes et résultats. - Dix triathlètes masculins (21,5 ± 2,8 ans) ont effectué une spirométrie et une mesure de la capacité de diffusion pulmonaire avant la compétition (pré-T) et 24 heures après l'épreuve (post-T). Les résultats montrent une diminution significative du volume expiratoire maximal en 1 s (5,17 ± 0,4 L.s-1 contre 4,09 ± 0,6 L.s-1) et du débit expiratoire maximal 25-75 % de la capacité vitale (6,98 ± 0,2 L.s-1 contre 4,90 ± 0,2 L.s-1). En revanche, les résultats ne montrent pas de différence significative entre les DLCO pré-T et post-T (38,1 ± 3,3 mL.min-1.mmHg-1 contre 37,1 ± 3,7 mL.min-1.mmHg-1) ni les ratios DLCO/VA (5,59 ± 0,5 mL.min-1.mmHg-1.A-1 contre 5,55 ± 0,7 ml.min-1.mmHg-1.A-1). Conclusion. - La DLCO est normale chez les triathlètes 24 heures après une compétition classique. Ceci peut traduire l'absence de lésions alvéolocapillaires pendant le triathlon. La baisse de la DLCO rapportée deux heures après un exercice dans la littérature peut s'expliquer par la baisse du volume sanguin pulmonaire qui apparaît comme un phénomène transitoire. Cependant, la baisse des débits pulmonaires observée 24 heures après le triathlon suggère la persistance chez les triathlètes d'un syndrome obstructif bronchique.
ISSN: 0765-1597

hal-00720522
https://hal.univ-antilles.fr/hal-00720522
https://hal.univ-antilles.fr/hal-00720522/document
https://hal.univ-antilles.fr/hal-00720522/file/Article_3_.pdf

Éditeur(s) : HAL CCSD Elsevier Masson
Résumé : International audience
Nous avons comparé les concentrations sanguines de lactate chez huit triathètes au cours d'un test triangulaire, avant et après (22,4 ± 2,6 heures) un triathlon classique. Les résultats montrent des concentrations sanguines de lactate significativement plus basses après le triathlon, malgré une puissance maximale (Pmax) et une consommation maximale d'oxygène (VO2max) comparables lors des deux tests triangulaires. Cette baisse des concentrations de lactate sanguin observée après le triathlon est interprétée comme étant le résultat d'une diminution des réserves de glycogène musculaire, d'une réutilisation plus grande du lactate produit, d'un recours plus important aux substrats lipidiques, ainsi que d'une diminution des catécholamines circulantes lors du test réalisé après le triathlon.
ISSN: 0765-1597

hal-00720458
https://hal.univ-antilles.fr/hal-00720458
DOI : 10.1016/S0765-1597(99)80005-7

Éditeur(s) : HAL CCSD
Résumé : International audience
Previous studies have reported respiratory, cardiac and muscle changes at rest in triathletes 24 h after completion of the event. To examine the effects of these changes on metabolic and cardioventilatory variables during exercise, eight male triathletes of mean age 21.1 (SD 2.5) years (range 17-26 years) performed an incremental cycle exercise test (IET) before (pre) and the day after (post) an official classic triathlon (1.5-km swimming, 40-km cycling and 10-km running). The IET was performed using an electromagnetic cycle ergometer. Ventilatory data were collected every minute using a breath-by-breath automated system and included minute ventilation (V(E)), oxygen uptake (VO2), carbon dioxide production (VCO2), respiratory exchange ratio, ventilatory equivalent for oxygen (V(E)/VO2) and for carbon dioxide (V(E)/VCO2), breathing frequency and tidal volume. Heart rate (HR) was monitored using an electrocardiogram. The oxygen pulse was calculated as VO2/HR. Arterialized blood was collected every 2 min throughout IET and the recovery period, and lactate concentration was measured using an enzymatic method. Maximal oxygen uptake (VO2max) was determined using conventional criteria. Ventilatory threshold (VT) was determined using the V-slope method formulated earlier. Cardioventilatory variables were studied during the test, at the point when the subject felt exhausted and during recovery. Results indicated no significant differences (P > 0.05) in VO2max [62.6 (SD 5.9) vs 64.6 (SD 4.8) ml x kg(-1) x min(-1)], VT [2368 (SD 258) vs 2477 (SD 352) ml x min(-1)] and time courses of VO2 between the pre- versus post-triathlon sessions. In contrast, the time courses of HR and blood lactate concentration reached significantly higher values (P < 0.05) in the pre-triathlon session. We concluded that these triathletes when tested 24 h after a classic triathlon displayed their pre-event aerobic exercise capacity, bud did not recover pretriathlon time courses in HR or blood lactate concentration.
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY

hal-00720432
https://hal.univ-antilles.fr/hal-00720432
https://hal.univ-antilles.fr/hal-00720432/document
https://hal.univ-antilles.fr/hal-00720432/file/Article_2.pdf

Éditeur(s) : HAL CCSD Oxford University Press (OUP)
Résumé : International audience
OBJECTIVES: Invasive fungal disease (IFD) remains a major concern in patients with haematological conditions. We describe diagnoses, therapeutic management and outcomes in unselected consecutive patients from haematological facilities treated for suspected or documented IFD. METHODS: In this observational prospective study, children/adults with haematological conditions or haematopoietic stem cell transplantation (HSCT) were recruited upon start of non-prophylactic systemic antifungal treatment in 37 French haematological facilities (December 2007 to December 2008). IFD episodes were classified according to the 2008 EORTC/MSG criteria. RESULTS: The cohort included 419 patients (298 adults and 121 children): 88% haematological malignancies, 28% HSCT recipients and 68% neutropenic. Patients had 423 IFD episodes: 21% mycologically documented (59% probable/proven aspergillosis, 32% proven candidiasis and 9% probable/proven other IFD) and 20% classified as possible IFD. The remaining cases were assigned to two groups: febrile neutropenia (34%) and unclassified (25%), 9% of which were classified as possible/probable/proven IFD by day 7. Treatment was thus initiated early in 59% of patients; liposomal amphotericin B and caspofungin were the most common single-agent therapies. The 12 week mortality was 18% for probable/proven aspergillosis, 15% for proven candidiasis, 10% for probable/proven other IFD, 9% for possible IFD, 3% for febrile neutropenia and 12% for unclassified episodes (log rank P = 0.016); it was dependent on age, complete remission of underlying haematological disease and mechanical ventilation. CONCLUSIONS: In this comprehensive sample of haematological patients receiving antifungal treatment, we observe a widespread resort to early therapy and a low mortality rate, including in patients with probable or proven IFD.
ISSN: 0305-7453

hal-00874741
https://hal.archives-ouvertes.fr/hal-00874741
DOI : 10.1093/jac/dks266
PUBMED : 22850692